Kura Oncology CEO Troy Wilson reports purchase of 100,000 common shares worth $1.11 million - KURA News | RalliesKura Oncology CEO Troy Wilson reports purchase of 100,000 common shares worth $1.11 million
K
KURA• CEO reports indirect share purchase and updated holdings
- Kura Oncology President and CEO Troy Edward Wilson reported an indirect purchase of 100,000 common shares at $11.12.
- Holdings tied to the One Fish Two Fish Revocable Trust rose to 379,194 shares.
- Wilson also reported 300,000 shares held indirectly via the Lorax Charitable Remainder Unitrust.
- He reported 435,456 common shares held directly.
GURE
•
